RI
BLTE

RTW Investments’s Belite Bio BLTE Stock Holding History

RTW Investments’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110M Hold
715,332
– – 0.94% 33
2026
Q1 		$114M Hold
715,332
– – 1.13% 28
2025
Q4 		$114M Buy
715,332
+402,832
+129% +$47.7M 1.15% 26
2025
Q3 		$23.1M Buy
+312,500
New +$20.5M 0.28% 53

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

RTW Investments's BLTE Position: Q2 2026 in Review

RTW Investments held its Belite Bio (BLTE) position steady in Q2 2026 at 715,332 shares worth $110M. The position accounts for 0.94% of the portfolio, ranked #33.

RTW Investments first reported a position in BLTE in Q3 2025 and has held it in 4 quarters since. The position peaked at $114M in Q4 2025. 81 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • RTW Investments held 715,332 shares of Belite Bio worth $110M as of Q2 2026.
  • RTW Investments left its Belite Bio share count unchanged in Q2 2026.
  • Belite Bio made up 0.94% of RTW Investments's portfolio in Q2 2026, its #33 holding.
  • RTW Investments first reported a position in Belite Bio in Q3 2025 and has held it in 4 quarters since.
  • RTW Investments's Belite Bio position peaked at $114M in Q4 2025.
  • 81 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.